Ownership as of December 30, 2020. Ten largest shareholders.
NamnA-aktierB-aktierAktiekapital %Röster %
ANNWALL & ROTHSCHILD INVESTMENTS AB377 736410 4787,0228,63
ÖHMAN BANK S.A.-1 174 01710,468,03
FJÄRDE AP-FONDEN-1 112 9199,917,61
SWEDBANK ROBUR NY TEKNIK BTI-579 1725,163,96
AMF AKTIEFOND SMÅBOLAG-501 5854,473,43
HANDELSBANKEN SVENSKA, SMABOLAGSFOND-450 6754,013,08
TREDJE AP-FONDEN-438 5653,913,00
CBNY-NORGES BANK-329 6202,942,25
UNIONEN-322 1962,872,20
DANGOOR, DAVID-278 4212,481,90
Summa 10 största ägare377 7365 597 64853,2364,09
Övriga aktieägare-5 250 80046,7735,91
Totalt377 73610 848 448100,00100,00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.